Japan Hospice Holdings Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	13,602	12,115	9,871	7,894	6,019	4,916
Revenue Growth (YoY)	18.03%	22.73%	25.04%	31.15%	22.44%	17.24%
Cost of Revenue	11,609	10,003	7,949	6,313	4,901	4,057
Gross Profit	1,993	2,112	1,922	1,581	1,118	859
Selling, General & Admin	519	425	344	384	343	332
Amortization of Goodwill & Intangibles	61	61	61	59	55	55
Other Operating Expenses	369	339	234	178	122	114
Operating Expenses	949	825	639	621	520	501
Operating Income	1,044	1,287	1,283	960	598	358
Interest Expense	-458	-431	-350	-282	-205	-156
Other Non Operating Income (Expenses)	223	151	94	104	23	4
EBT Excluding Unusual Items	811	1,007	1,027	782	416	206
Other Unusual Items	3	-	-	1	-	-
Pretax Income	814	1,007	1,027	783	416	206
Income Tax Expense	308	368	346	305	176	99
Earnings From Continuing Operations	506	639	681	478	240	107
Minority Interest in Earnings	-	-	-	-24	-	-
Net Income	506	639	681	454	240	107
Net Income to Common	506	639	681	454	240	107
Net Income Growth	-9.64%	-6.17%	50.00%	89.17%	124.30%	-63.97%
Shares Outstanding (Basic)	8	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change (YoY)	1.25%	3.73%	0.14%	0.47%	-0.03%	3.98%
EPS (Basic)	60.54	77.88	84.71	56.64	30.19	13.61
EPS (Diluted)	60.11	76.19	84.26	56.27	29.84	13.30
EPS Growth	-10.66%	-9.58%	49.74%	88.57%	124.36%	-65.45%
Free Cash Flow	-	-2,248	-852	350	-1,440	-248
Free Cash Flow Per Share	-	-267.81	-105.29	43.31	-179.04	-30.82
Dividend Per Share	15.000	15.000	-	-	-	-
Gross Margin	14.65%	17.43%	19.47%	20.03%	18.57%	17.47%
Operating Margin	7.67%	10.62%	13.00%	12.16%	9.93%	7.28%
Profit Margin	3.72%	5.27%	6.90%	5.75%	3.99%	2.18%
Free Cash Flow Margin	-	-18.56%	-8.63%	4.43%	-23.92%	-5.04%
EBITDA	1,665	1,818	1,694	1,295	825	526
EBITDA Margin	12.24%	15.01%	17.16%	16.41%	13.71%	10.70%
D&A For EBITDA	621	531	411	335	227	168
EBIT	1,044	1,287	1,283	960	598	358
EBIT Margin	7.67%	10.62%	13.00%	12.16%	9.93%	7.28%
Effective Tax Rate	37.84%	36.54%	33.69%	38.95%	42.31%	48.06%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.